Costa Rica vs Mauritania: Antiretroviral therapy coverage for PMTCT
Costa Rica
42.0%
in 2024
Mauritania
39.0%
in 2024
Costa Rica rank
70th
Mauritania rank
73rd
Antiretroviral therapy coverage for PMTCT over time
- Costa Rica
- Mauritania
How they compare
Costa Rica currently reports 42.0% against 39.0% in Mauritania, a difference of 3.0%.
That makes Costa Rica's figure about 1.1 times Mauritania's.
The two have swapped places 3 times across 22 shared years of data; in 2000 it was Mauritania ahead.
Costa Rica ranks 70th and Mauritania ranks 73rd of 84 countries.
Costa Rica has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Costa Rica | Mauritania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.5% | 2.0% | 22.5% | Costa Rica |
| 2010s | 81.0% | 32.9% | 48.1% | Costa Rica |
| 2020s | 70.4% | 28.4% | 42.0% | Costa Rica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Costa Rica or Mauritania?
- Costa Rica, at 42.0% against 39.0% in Mauritania as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Costa Rica and Mauritania?
- 3.0%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and Mauritania?
- 22 years are reported by both, from 2000 to 2024.
- How do Costa Rica and Mauritania rank globally for antiretroviral therapy coverage for pmtct?
- Costa Rica ranks 70th and Mauritania ranks 73rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).